Workflow
Danimer Scientific(DNMR)
icon
Search documents
Danimer Scientific(DNMR) - 2022 Q3 - Earnings Call Transcript
2022-11-09 02:00
Danimer Scientific, Inc. (NYSE:DNMR) Q3 2022 Results Conference Call November 8, 2022 5:00 PM ET Company Participants Steve Croskrey - CEO Mike Hajost - CFO Conference Call Participants Jon Tanwanteng - CJS Securities Laurence Alexander - Jefferies Thomas Boyes - Cowen & Company Operator Thank you for standing by. This is the conference operator. Welcome to the Danimer Scientific, Inc. Third Quarter 2022 Earnings Conference Call. As a reminder, all participants are in a listen-only mode and the conference i ...
Danimer Scientific(DNMR) - 2022 Q3 - Quarterly Report
2022-11-07 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 001-39280 | --- | --- | --- | |----------------------------------------------------------------------------------------------------- ...
Danimer Scientific(DNMR) - 2022 Q2 - Earnings Call Transcript
2022-08-10 01:28
Danimer Scientific, Inc. (NYSE:DNMR) Q2 2022 Earnings Conference Call August 9, 2022 5:00 PM ET Company Participants Russ Zukowski - President, Corporate Finance Stephen Croskrey - CEO Mike Hajost - CFO Conference Call Participants Pete Lucas - CJS Securities Thomas Boyes - Cowen & Company Operator Greetings. Welcome to the Danimer Scientific Second Quarter 2022 Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Oper ...
Danimer Scientific(DNMR) - 2022 Q2 - Quarterly Report
2022-08-08 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 001-39280 | --- | --- | --- | |---------------------------------------------------------------------------------------------------------- ...
Danimer Scientific(DNMR) - 2022 Q1 - Earnings Call Transcript
2022-05-11 00:11
Danimer Scientific, Inc. (NYSE:DNMR) Q1 2022 Earnings Conference Call May 10, 2022 5:00 PM ET Company Participants Russ Zukowski - VP, Corporate Finance Stephen Croskrey - CEO Michael Hajost - CFO Conference Call Participants Jon Tanwanteng - CJS Securities Laurence Alexander - Jefferies Thomas Boyes - Cowen & Company Operator Greetings, and welcome to the Danimer Scientific First Quarter 2022 Conference Call. At this all participants are in a listen-only mode. A question-and-answer session will follow the ...
Danimer Scientific(DNMR) - 2022 Q1 - Quarterly Report
2022-05-09 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 001-39280 DANIMER SCIENTIFIC, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 84-1924518 ( State or other jurisdict ...
Danimer Scientific(DNMR) - 2021 Q4 - Annual Report
2022-03-07 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39280 DANIMER SCIENTIFIC, INC. (Exact name of Registrant as specified in its Charter) Delaware 84-1924518 (State or other jurisdictio ...
Danimer Scientific(DNMR) - 2021 Q4 - Earnings Call Transcript
2022-03-01 03:12
Danimer Scientific, Inc. (NYSE:DNMR) Q4 2021 Earnings Conference Call February 28, 2022 5:00 PM ET Company Participants Russ Zukowski - VP, Corporate Finance Stephen Croskrey - CEO & Chairman John Dowdy - CFO & Secretary Michael Hajost - Incoming CFO Conference Call Participants Laurence Alexander - Jefferies Jonathan Tanwanteng - CJS Securities Thomas Boyes - Cowen and Company Operator Greetings, and welcome to Danimer Scientific Fourth Quarter and Full Year 2021 Earnings Call. [Operator Instructions]. As ...
Danimer Scientific(DNMR) - 2021 Q3 - Earnings Call Transcript
2021-11-16 01:55
Danimer Scientific, Inc. (NYSE:DNMR) Q3 2021 Earnings Conference Call November 15, 2021 5:00 PM ET Company Participants Steve Croskrey – CEO Jad Dowdy – CFO Russ Zukowski – Vice President, Corporate Finance Phillip Van Trump – Chief Science and Technology Conference Call Participants Laurence Alexander – Jefferies Jon Tanwanteng – CJS Securities Thomas Boyes – Cowen and Company Operator Greetings and welcome to the Danimer Scientific Third Quarter 2021 Earnings Call. At this time, all participants are in a ...
Danimer Scientific(DNMR) - 2021 Q3 - Quarterly Report
2021-11-14 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common stock, $0.0001 par value per share DNMR New York Stock Exchange FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fr ...